The monthly variation in geometric mean MICs (GMICs) of amikacin, tobramycin, and gentamicin for Escherichia coli and Pseudonionas aeruginosa laboratory controls and clinicai isolates was followed for 30 months. For 19 months, MICs were determined by using Micro-Media system (MMS; Micro-Media Systems, Inc., Potomac, Md.) microdilution panels, and for the other 11 months, MicroScan (MS; American Scientific Products, McGaw Park, Ill.) MIC test panels were used. The aminoglycoside GMICs for control E. coli and P. aeruginosa were significantly lower with the MS system than with the MMS system. A significant correlation was observed between the GMICs for controls and clinical isolates more frequently with the MMS system than with the MS system. Differences are believed to be related to the criteria used in the selection of quality control strains.
During an ongoing surveillance program which monitors the susceptibility of microorganisms to antibiotics at the Minneapolis (Minn.) Veterans Administration Medical Center, the monthly geometric mean MICs (GMICs) for clinical isolates were observed to fluctuate (Fig. 1 ). These variations were dynamic. The purpose of this investigation was (i) to determine whether these fluctuations should have been expected, by looking at the daily performance of reference bacteria, and (ii) to see whether there are any differences in prediction capacity between two commercially available microdilution MIC panels. 
MATERIALS AND METHIODS

DISCUSSION
The routine use of commercially available microdilution systems for quantitative MIC determinations has become increasingly common. The attractive qualities of these systems have been reviewed elsewhere (1, 8) . A number of reports have shown these systems to be comparable in accuracy and reproducibility (1, 5, 10) . Our experience with the MMS and MS systems shows that each method is in compliance with the standards of the National Committee for Clinical Laboratory Standards for quality control (QC) performance (6) . Although it is similar to other reports, we believe this study uniquely shows, first, that the GMICs and modal MICs for the QC organisms were significantly differept between the MMS and MS systems and, second, that there was a significant correlation between GMICs for QC strains and clinical isolates with a microdilution system ( Fig.  1 ; Table 2 ).
When changing from the MMS to the MS system, our laboratory compared the two systems on a limited basis and found them similar (unpublished data). However, after extended use of each, we found that the GMICs and modal MICs for reference strains of E. coli and P. aeruginosa were, with one exception, significantly lower with the MS system.
Although the reasons for this difference are purely speculative, several appear to be likely, including medium differences (2, 4, 7, 8) , the method of calcium and magnesium supplementation, subtle variations in transfer lids, seed troughs, or panel well shape, and various antibiotic concentrations within the wells. This study was unable to explain the difference in QC modal MICs; however, the important implication is that clinical isolate MICs would be affected in a similar fashion.
Although observed only once with the MS system, there was a strong correlation between QC GMICs and those for clinical isolates with the MMS system (Table 2; Fig. 1 ). This was observed most often when the GMIC varied 10% or more from the modal MIC, and less than 85% of the determinations were modal. First, we suspect that this may reflect how responsive the reference strains are to fluctuations in the systems used. This is consistent with the observations of Woolfrey et al., who showed that system performance was slightly different with selected strains of P. aeruginosa (9, 10) . For example, with the MMS system, the QC GMICs were often between serial dilutions, thereby making them very responsive to small changes in the system. The one time this was observed with the MS system, when the GMIC of amikacin for E. coli was 1.5 ,ug/ml, there was also significaqt correlation (Tables 1 and 2 ). Also, we suspect that the QC organisms used in this study are not able to show variations in the MS system, because the lowest dilution concentrations may be greater than the actual MICs for the control organisms. The modal MIC (Table 1) in four of six cases was equal to the lowest serial dilution concentration.
In conclusion, we found that QC MICs from the MS and MMS systems were statistically different and that variations in GMICs for clinical isolates are often mimicked by the GMICs for control strains. In our estimation, both observations are at least in part related to the criteria used in the selection of the QC strains. The methodology of one of the Nineteen months of daily control data (n = 484).
Eleven months of daily control data (n = 315). d Significantly different from MMS (P < 0.05). 
